PSA Net vs ProstPlanAI
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
PSA Net
This medical app uses a neural network to predict the likelihood of prostate cancer on biopsy. It considers patient data such as age, PSA levels, symptom scores, ethnicity, family history, and rectal exam results. It is designed for use by qualified healthcare professionals.
- Prostate cancer prediction
- Neural network analysis
- Patient data input
- Biopsy likelihood assessment
- Healthcare professional tool
Read full descriptionHide full description
PSA Net is a neural network that predicts whether a man will have prostate cancer on biopsy from the patient's age, total PSA, complexed PSA, results of the International Prostate Symptom Score, ethnicity, family history and rectal exam. It is intended to be used by qualified healthcare professionals. The application is an adaptation of the algorithm published in Kalra P, Togami J, Bansal B S G, Partin AW, Brawer MK, Babaian RJ, Ross LS, Niederberger CS: A neurocomputational model for prostate carcinoma detection: Cancer 2003 Nov 1;98(9):1849-54.
ProstPlanAI
Read full descriptionHide full description
ProstPlanAI is a clinical decision-support app for qualified healthcare professionals involved in prostate cancer assessment and surgical planning. The app helps organize biopsy, MRI, and clinical information in one place, supporting case review with structured inputs, physician-facing calculations, 3D visualization, and PDF summaries. Key features: • AI-assisted extraction of structured information from medical PDF reports • PRECE-based sector visualization support • Interactive 3D prostate visualization with lesion mapping • PLND risk support • Trifecta outcome support • MSKCC nomogram support • Tumor volume estimation support • PDF export for case documentation and discussion • Saved patient sessions and workflow continuity • Optimized for iPhone and iPad Important: ProstPlanAI is intended for use by qualified healthcare professionals only. It is a decision-support tool and does not provide autonomous diagnosis or treatment recommendations. AI-assisted extracted information, calculations, visualizations, and reports must be reviewed and validated by a licensed clinician. The app does not replace clinical judgment, pathology review, radiology review, institutional protocols, multidisciplinary discussion, or guideline-based decision-making. Terms of Use: https://www.prostplanai.com/terms-en Privacy Policy: https://www.prostplanai.com/privacy-en
Screenshots
Verdict
The clearest difference is in-app purchases: PSA Net at none against ProstPlanAI's 2. PSA Net also leads on iOS requirement (16.6 vs 26.0). ProstPlanAI's advantage is update cadence (every 3 days vs every 103 months) and device support (3 vs 1). On price and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. ProstPlanAI sells 2 in-app purchases, starting at $24.99 per month. PSA Net asks for nothing beyond the download.
PSA Net ships an update every 103 months, ProstPlanAI every 3 days. The most recent releases landed on October 23, 2026 and October 25, 2026 respectively.
| Parameter | PSA Net | ProstPlanAI |
|---|---|---|
| Price | Free | Free |
| Rating | 2.3 (38 ratings) — better | — |
| Positive reviews | 33.3% of reviews | — |
| Number of ratings | 38 — better | — |
| Update frequency | Every 103 months | Every 3 days — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free | — |
| Devices | iPhone | iPhone, iPad, Mac — better |
| Requires iOS | 16.6 — better | 26.0 |
| Further details — not scored | ||
| Size | 1 MB | 19 MB |
| Age rating | 4+ | 17+ |
| Developer | Niedertronics | Sergio Cardoso |
In-app purchases
PSA Net
No in-app purchases
ProstPlanAI
- Premium Individual Subscription7 Days trial$24.991 Month
- Premium Yearly Subscription7 Days trial$239.001 Year









